Bioflight
Akron, US · Delaware LLC
Biotech
Founders & leadership
RS
Richard ShortenRichard Shorten is the Chief Executive Officer of Issuer
Reported raises · per SEC filings
Form D private placements▶$400KraisedMay 2022 · 4 investors · BiotechnologyRule 506(b)
▶$400KraisedMay 2022 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard ShortenExecutive Officer
- Offering amount
- $2.4M
- Amount sold
- $400K
- Minimum investment
- $25K
- First sale
- Jan 2022
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.